Compounds > ciprofloxacin

ciprofloxacin and rifaximin

ciprofloxacin has been researched along with rifaximin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, J; Cleary, TG; Gonzales, E; Ochoa, TJ; Walker, CM1
Bastide, L; Gualtieri, M; Leonetti, JP; Villain-Guillot, P1
Biedenbach, DJ; Fritsche, TR; Jones, RN1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for ciprofloxacin and rifaximin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

4 other study(ies) available for ciprofloxacin and rifaximin

ArticleYear
Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Anti-Infective Agents; Bacteriolysis; Child; Child, Preschool; Coliphages; Diarrhea; Escherichia coli; Escherichia coli Infections; Escherichia coli O157; Hemolytic-Uremic Syndrome; Humans; Lysogeny; Rifamycins; Rifaximin; Shiga Toxins; Virus Activation

2007
In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilm.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Amidines; Anti-Bacterial Agents; Biofilms; Colony Count, Microbial; DNA-Directed RNA Polymerases; Enzyme Inhibitors; Hydroxylamines; Luminescence; Rifampin; Staphylococcus epidermidis; Structure-Activity Relationship; Transcription, Genetic

2007
Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler's diarrhea.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Anti-Bacterial Agents; Diarrhea; Dioxolanes; Fluoroquinolones; Gastroenteritis; Gram-Negative Bacteria; Humans; Piperazines; Population Surveillance; Prodrugs

2009
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013